炎症
脂肪组织
胰岛素抵抗
中性粒细胞弹性蛋白酶
免疫系统
弹性蛋白酶
脂肪组织巨噬细胞
蛋白酵素
巨噬细胞
免疫学
内分泌学
生物
内科学
胰岛素
医学
体外
生物化学
酶
作者
Saswata Talukdar,Da Young Oh,Gautam Bandyopadhyay,Dongmei Li,Jianfeng Xu,Joanne McNelis,Min Lü,Pingping Li,Qingyun Yan,Yimin Zhu,Jachelle M. Ofrecio,Michael Lin,Martin Brenner,Jerrold M. Olefsky
出处
期刊:Nature Medicine
[Nature Portfolio]
日期:2012-08-05
卷期号:18 (9): 1407-1412
被引量:926
摘要
Infiltration of various immune cell types into the fat tissue and liver has been implicated in obesity-induced insulin resistance. Jerry Olefsky and his colleagues now show that neutrophils are one of the earliest immune cells to arrive in these tissues, that they release the protease neutrophil elastase and that this enzyme degrades IRS-1, a key member of the insulin signaling pathway. These results show that neutrophils contribute to insulin resistance and how they may do so. Chronic low-grade adipose tissue and liver inflammation is a major cause of systemic insulin resistance and is a key component of the low degree of insulin sensitivity that exists in obesity and type 2 diabetes1,2. Immune cells, such as macrophages, T cells, B cells, mast cells and eosinophils, have all been implicated as having a role in this process3,4,5,6,7,8. Neutrophils are typically the first immune cells to respond to inflammation and can exacerbate the chronic inflammatory state by helping to recruit macrophages and by interacting with antigen-presenting cells9,10,11. Neutrophils secrete several proteases, one of which is neutrophil elastase, which can promote inflammatory responses in several disease models12. Here we show that treatment of hepatocytes with neutrophil elastase causes cellular insulin resistance and that deletion of neutrophil elastase in high-fat-diet–induced obese (DIO) mice leads to less tissue inflammation that is associated with lower adipose tissue neutrophil and macrophage content. These changes are accompanied by improved glucose tolerance and increased insulin sensitivity. Taken together, we show that neutrophils can be added to the extensive repertoire of immune cells that participate in inflammation-induced metabolic disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI